Genmab A/S (CPH:GMAB)
Denmark
· Delayed Price · Currency is DKK 1,340.50
+10.50 (0.79%)
Apr 24, 2025, 3:00 PM CET
Genmab Market Cap
Genmab has a market cap or net worth of 83.24 billion as of April 24, 2025. Its market cap has decreased by -37.88% in one year.
Market Cap
83.24B
Enterprise Value
63.16B
Revenue
21.53B
Ranking
n/a
PE Ratio
10.96
Stock Price
1,340.50
Market Cap Chart
Since October 18, 2000, Genmab's market cap has increased from 3.68B to 83.24B, an increase of 2,159.28%. That is a compound annual growth rate of 13.55%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1,731.23B |
| Coloplast | 159.01B |
| Demant | 47.63B |
| ALK-Abelló | 32.87B |
| Ambu A/S | 29.86B |
| Zealand Pharma | 28.02B |
| H. Lundbeck | 26.49B |
| GN Store Nord | 13.68B |